Exane Derivatives’s Becton Dickinson BDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-74
Closed -$19.2K 803
2022
Q1
$19.2K Sell
74
-1,494
-95% -$385K 0.01% 665
2021
Q4
$385K Sell
1,568
-834
-35% -$200K 0.09% 219
2021
Q3
$576K Buy
2,402
+1,784
+289% +$438K 0.14% 160
2021
Q2
$150K Buy
+618
New +$148K 0.03% 480
2021
Q1
Sell
-1,486
Closed -$363K 921
2020
Q4
$363K Buy
1,486
+155
+12% +$36.1K 0.11% 224
2020
Q3
$302K Sell
1,331
-446
-25% -$110K 0.09% 178
2020
Q2
$415K Buy
1,777
+1,457
+455% +$351K 0.11% 164
2020
Q1
$71.7K Hold
320
0.02% 321
2019
Q4
$86.5K Buy
320
+67
+26% +$16.7K 0.02% 334
2019
Q3
$62.5K Hold
253
0.01% 354
2019
Q2
$62.2K Buy
+253
New +$58.8K 0.01% 372
2019
Q1
Sell
-2,277
Closed -$500K 673
2018
Q4
$500K Buy
2,277
+1,507
+196% +$350K 0.09% 178
2018
Q3
$196K Buy
770
+21
+3% +$5.17K 0.04% 247
2018
Q2
$176K Buy
749
+11
+1% +$2.45K 0.03% 274
2018
Q1
$153K Buy
738
+18
+3% +$3.94K 0.03% 254
2017
Q4
$150K Buy
720
+644
+847% +$135K 0.03% 259
2017
Q3
$14.5K Buy
76
+39
+105% +$7.56K ﹤0.01% 372
2017
Q2
$7.02K Buy
+37
New +$6.76K ﹤0.01% 421
2015
Q4
Sell
-416
Closed -$53.9K 527
2015
Q3
$53.9K Buy
+416
New +$58.1K 0.01% 258

Other funds holding BDX

Exane Derivatives's BDX Position: Q2 2022 in Review

Exane Derivatives sold out of Becton Dickinson (BDX) in Q2 2022, closing a stake of 74 shares — an estimated $19.2K sold.

Exane Derivatives first reported a position in BDX in Q3 2015 and held it in 19 quarters. The position peaked at $576K in Q3 2021. 1,536 funds tracked by Wall St. Rank hold BDX as of Q2 2022.

  • Exane Derivatives reported no remaining Becton Dickinson position as of Q2 2022 after selling out during the quarter.
  • Exane Derivatives sold 74 Becton Dickinson shares in Q2 2022, an estimated $19.2K.
  • Exane Derivatives first reported a position in Becton Dickinson in Q3 2015 and held it in 19 quarters.
  • Exane Derivatives's Becton Dickinson position peaked at $576K in Q3 2021.
  • 1,536 funds tracked by Wall St. Rank held Becton Dickinson as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.